drugset / Trial / NCT01448434

Allogeneic Mesenchymal Stem Cells for Osteoarthritis

NCT01448434

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is designed to know the safety and efficacy of 2 different doses of mesenchymal stem cells in patients suffering from osteoarthritis of knee joint.

Timeline

Start
2011-09
Primary completion
2013-09
Completion
2013-09

Drugs

EvaluationDrugModalityDoseRoute
Subject allogeneic MSCs Cell therapy Other
Background Hyaluronic Acid Other / unclassified 2 ml Other

Indications